Skip to content

Effect of Ultrasound-Guided Rhomboid Intercostal and Sub-Serratus Plane Block on Pulmonary Complications after Multiple Rib Fractures

Effect of Ultrasound-Guided Rhomboid Intercostal and Sub-Serratus Plane Block on Pulmonary Complications after Multiple Rib Fractures

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119107
Enrollment
Unknown
Registered
2026-02-23
Start date
2026-02-23
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple rib fractures

Interventions

Experimental group:Receive RISS block analgesia
Control group:Receive continuous infusion of the traditional intravenous analgesic drug butorphanol, and 50mg of flurbiprofen axetil every 12 hours. The dosage of the analgesic drugs will be adjusted

Sponsors

Foshan Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. ASA classification levels I-IV; 2. Age over 18 years old, body mass index (BMI) ranging from 18 to 28 kg/m^2; 3. Complete clinical data of the patient; 4. No infection at the puncture site before treatment; 5. Good patient compliance, and the patient's family members have signed the relevant informed consent form.

Exclusion criteria

Exclusion criteria: 1. Diabetic patients; 2. Patients with a history of chronic lung disease or history of lung surgery before the trauma; 3. Patients receiving tracheal intubation and ventilator-assisted ventilation; 4. Patients with poor consciousness and inability to cooperate; 5. Patients with severe thoracic deformity or severe lung disease in the past; 6. Patients known to be allergic to anesthesia-related drugs; 7. Patients with opioid abuse; 8. Patients with chronic chest wall pain in the past; 9. Patients with severe bleeding or coagulation disorders; 10. Patients with severe systemic diseases; 11. Patients with a history of mental illness.

Design outcomes

Primary

MeasureTime frame
Modified LUS scoring system;Oxygenation index (PaO2/FiO2) at T1, T2, and T3;Incidence of new-onset pulmonary complications within 7 days after T0, including emergency tracheal intubation, type I or II respiratory failure, pneumothorax, pleural effusion, acute respiratory distress syndrome, various upper airway obstructions, and pulmonary infections.;

Secondary

MeasureTime frame
Cumulative consumption of analgesic medication;Resting and coughing VAS scores at each time point;ICU length of stay;Difference in LUS scores between T1 and T0 time points;

Countries

China

Contacts

Public ContactRuimin Luo

Foshan Hospital of Traditional Chinese Medicine

394224684@qq.com+86 155 2102 0977

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026